Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Capital Expenditures: 2018-2023

Historic Capital Expenditures for Black Diamond Therapeutics (BDTX) over the last 6 years, with Dec 2023 value amounting to $33,000.

  • Black Diamond Therapeutics' Capital Expenditures rose 205.50% to $333,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $2.7 million, marking a year-over-year increase of 1781.94%. This contributed to the annual value of $33,000 for FY2023, which is 82.81% down from last year.
  • According to the latest figures from FY2023, Black Diamond Therapeutics' Capital Expenditures is $33,000, which was down 82.81% from $192,000 recorded in FY2022.
  • Over the past 5 years, Black Diamond Therapeutics' Capital Expenditures peaked at $2.7 million during FY2021, and registered a low of $21,000 during FY2019.
  • Its 3-year average for Capital Expenditures is $978,333, with a median of $192,000 in 2022.
  • As far as peak fluctuations go, Black Diamond Therapeutics' Capital Expenditures spiked by 1,808.45% in 2021, and later slumped by 92.92% in 2022.
  • Over the past 5 years, Black Diamond Therapeutics' Capital Expenditures (Yearly) stood at $21,000 in 2019, then surged by 576.19% to $142,000 in 2020, then surged by 1,808.45% to $2.7 million in 2021, then tumbled by 92.92% to $192,000 in 2022, then plummeted by 82.81% to $33,000 in 2023.